Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer

British Journal of Cancer

Volumn 74, Issue 6, 1996, Pages 871-873

  Lehrer, S ^a   Terk, M ^a   Piccoli, S P ^b   Song, H K ^a   Lavagnini, P ^a   Luderer, A A ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b Dianon Systems   (United States)

Author keywords

Breast cancer; Circulating tumour cell; Prostate specific antigen; RT PCR

Indexed keywords

EDETIC ACID; ESTROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VENOUS BLOOD;

EID: 0029756624     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.450     Document Type: Article

References (14)

1. DATTA YH, ADAMS PT, DROBYSKI WR, ETHIER SP, TERRY VH AND ROTH MS. (1994). Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol., 12, 475-482.
2. DIAMANDIS EP AND YU H. (1995). New biological functions of prostate-specific antigen? (editorial). J. Clin. Endocrinol. Metab., 80, 1515-1517.
3. DIAMANDIS EP, YU H AND SUTHERLAND DJ. (1994). Detection of prostate-specific antigen immunoreactivity in breast tumours. Breast Cancer Res. Treat., 32, 301.
4. FISHER B. (1990). Laboratory and clinical research in breast cancer - a personal adventure: the David A Karnovsky Memorial Lecture. Cancer Res., 40, 3863-3874.
5. GHOSSEIN RA, SCHER HI. GERALD WL, KELLY WK, CURLEY T, AMSTERDAM A, ZHANG ZF AND ROSAI J. (1995). Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J. Clin. Oncol., 13, 1195-1200.
6. KATZ AE, OLSSON CA, RAFFO AJ, CAMA C, PERLMAN H, SEAMAN E, O'TOOLE KM, MCMAHON D, BENSON MC AND BUTTYAN R. (1994). Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43, 765-775.
7. KATZ AE, DE VRIES GM, BEGG MD, RAFFO AJ, CAMA C, O'TOOLE K, BUTTYAN R, BENSON MC AND OLSSON CA. (1995). Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer, 75, 1642-1648.
8. LEITNER SP, SWERN AS, WEINBERGER D, DUNCAN LJ AND HUTTER RVP. (1995). Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer. Cancer, 76, 2266-2274.
9. MONNE M, CROCE CM, YU H AND DIAMANDIS EP. (1994). Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors. Cancer Res., 54, 6344-6347.
10. MORENO JA, CROCE CM, FISCHER R, MONNE M, VIHKO S, MULHOLLAND SG AND GOMELLA LA. (1992). Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52, 6110-6112.
11. NOGUCHI S, AIHARA T, NAKAMORI S, MOTOMURA K, INAJI H, IMAOKA S AND KOYAMA H. (1994). The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer, 74, 1595-1600.
12. REYNOLDS T. (1994). Breast cancer prognostic factors the search goes on. J. Natl Cancer Inst., 86, 480-485.
13. YU H, DIAMANDIS EP AND SUTHERLAND DJ. (1994). Immuno reactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin. Biochem., 27, 75-79.
14. YU H, GIAI M, DIAMANDIS EP, KATSAROS D, SUTHERLAND DJA, LEVESQUE MA, ROAGNA R, PONZONE R AND SISMONDI P. (1995). Prostate-specific antigen is a new favorable prognosticindicator for women with breast cancer. Cancer Res., 55, 2104-2110.